FOXA1 is an essential determinant of ERα expression and mammary ductal morphogenesis

FOXA1, estrogen receptor α (ERα) and GATA3 independently predict favorable outcome in breast cancer patients, and their expression correlates with a differentiated, luminal tumor subtype. As transcription factors, each functions in the morphogenesis of various organs, with ERα and GATA3 being established regulators of mammary gland development. Interdependency between these three factors in breast cancer and normal mammary development has been suggested, but the specific role for FOXA1 is not known. Herein, we report that Foxa1 deficiency causes a defect in hormone-induced mammary ductal invasion associated with a loss of terminal end bud formation and ERα expression. By contrast, Foxa1 null glands maintain GATA3 expression. Unlike ERα and GATA3 deficiency, Foxa1 null glands form milk-producing alveoli, indicating that the defect is restricted to expansion of the ductal epithelium, further emphasizing the novel role for FOXA1 in mammary morphogenesis. Using breast cancer cell lines, we also demonstrate that FOXA1 regulates ERα expression, but not GATA3. These data reveal that FOXA1 is necessary for hormonal responsiveness in the developing mammary gland and ERα-positive breast cancers, at least in part, through its control of ERα expression.

[1]  Zena Werb,et al.  Stromal Effects on Mammary Gland Development and Breast Cancer , 2002, Science.

[2]  K. Kaestner,et al.  Mild Nephrogenic Diabetes Insipidus Caused by Foxa1 Deficiency* , 2004, Journal of Biological Chemistry.

[3]  Charles M Perou,et al.  FOXA1 Expression in Breast Cancer—Correlation with Luminal Subtype A and Survival , 2007, Clinical Cancer Research.

[4]  R. Weinberg,et al.  A paracrine role for the epithelial progesterone receptor in mammary gland development. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Strausberg,et al.  Mutation of GATA3 in human breast tumors , 2004, Oncogene.

[6]  Clifford A. Meyer,et al.  FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific Transcription , 2008, Cell.

[7]  Jonathan P. Katz,et al.  Inactivation of the winged helix transcription factor HNF3alpha affects glucose homeostasis and islet glucagon gene expression in vivo. , 1999, Genes & development.

[8]  Céline Lefebvre,et al.  From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. A. Hamilton,et al.  Expression and amplification of cyclin genes in human breast cancer. , 1993, Oncogene.

[10]  Z. Werb,et al.  GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. , 2008, Cancer cell.

[11]  Clifford A. Meyer,et al.  Chromosome-Wide Mapping of Estrogen Receptor Binding Reveals Long-Range Regulation Requiring the Forkhead Protein FoxA1 , 2005, Cell.

[12]  S. Haslam,et al.  The ontogeny and cellular distribution of estrogen receptors in normal mouse mammary gland , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  F. Gannon,et al.  Human estrogen receptor-α: regulation by synthesis, modification and degradation , 2002, Cellular and Molecular Life Sciences CMLS.

[14]  L. Young,et al.  Preparing Mammary Gland Whole Mounts from Mice , 2000 .

[15]  Jérôme Eeckhoute,et al.  A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. , 2006, Genes & development.

[16]  M. Stoffel,et al.  Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Marie-Liesse Asselin-Labat,et al.  Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation , 2007, Nature Cell Biology.

[18]  A. Howell,et al.  Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: Analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression , 1997, Breast Cancer Research and Treatment.

[19]  L. Hennighausen,et al.  Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  James A. Clark,et al.  Mammary Gland Development in Adult Mice Requires Epithelial and Stromal Estrogen Receptor α. , 2002, Endocrinology.

[21]  L. Wakefield,et al.  TGF-beta signaling in mammary gland development and tumorigenesis. , 2001, Journal of mammary gland biology and neoplasia.

[22]  G. Cunha,et al.  Transplantation and Tissue Recombination Techniques to Study Mammary Gland Biology , 2000 .

[23]  L. Wakefield,et al.  TGF-β Signaling in Mammary Gland Development and Tumorigenesis , 2004, Journal of Mammary Gland Biology and Neoplasia.

[24]  M. Montano,et al.  The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1 , 2005, Oncogene.

[25]  J. Eeckhoute,et al.  Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. , 2007, Cancer research.

[26]  S. Robinson,et al.  TGF-beta 1-induced inhibition of mouse mammary ductal growth: developmental specificity and characterization. , 1989, Developmental biology.

[27]  P. Chambon,et al.  Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. , 2000, Development.

[28]  Y Wang,et al.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[29]  G. Ball,et al.  Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance. , 2008, European journal of cancer.

[30]  K. Kaestner,et al.  Stage-specific regulation of respiratory epithelial cell differentiation by Foxa1. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[31]  K. Wagner,et al.  Estrogen receptor-α expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice , 2007, Proceedings of the National Academy of Sciences.

[32]  D. Stern,et al.  ErbB3 is required for ductal morphogenesis in the mouse mammary gland , 2008, Breast Cancer Research.

[33]  François Vaillant,et al.  Generation of a functional mammary gland from a single stem cell , 2006, Nature.

[34]  Jérôme Eeckhoute,et al.  Positive Cross-Regulatory Loop Ties GATA-3 to Estrogen Receptor α Expression in Breast Cancer , 2007 .

[35]  F. Maurer,et al.  The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Michael D. Abràmoff,et al.  Image processing with ImageJ , 2004 .

[37]  J. Hanoune.  Amphiregulin is an essential mediator of estrogen receptor a function in mammary gland development. , 2007 .

[38]  Debashis Ghosh,et al.  Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. , 2005, Cancer research.

[39]  R. Strausberg,et al.  Mutation of GATA 3 in human breast tumors , 2004 .

[40]  S. Bellusci,et al.  Terminal end bud maintenance in mammary gland is dependent upon FGFR2b signaling. , 2008, Developmental biology.

[41]  Alan Ashworth,et al.  Stem cells and breast cancer: A field in transit , 2003, Nature Reviews Cancer.

[42]  Jérôme Eeckhoute,et al.  A cell-type-specific transcriptional network required for estrogen regulation of cyclin D 1 and cell cycle progression in breast cancer , 2006 .

[43]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[44]  F. Gannon,et al.  Human estrogen receptor-alpha: regulation by synthesis, modification and degradation. , 2002, Cellular and molecular life sciences : CMLS.

[45]  S. Anderson,et al.  An Atlas of Mouse Mammary Gland Development , 2004, Journal of Mammary Gland Biology and Neoplasia.

[46]  James A. Clark,et al.  Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha. , 2002, Endocrinology.

[47]  Cathrin Brisken,et al.  Amphiregulin is an essential mediator of estrogen receptor α function in mammary gland development , 2007, Proceedings of the National Academy of Sciences.

[48]  L. Hennighausen,et al.  Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene , 2001, Oncogene.

[49]  R. Caprioli,et al.  Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation , 2005, Development.

[50]  Zena Werb,et al.  GATA-3 Maintains the Differentiation of the Luminal Cell Fate in the Mammary Gland , 2006, Cell.

[51]  D. Accili,et al.  Rescue of Mammary Epithelium of Early Lethal Phenotypes by Embryonic Mammary Gland Transplantation as Exemplified with Insulin Receptor Null Mice , 2000 .

[52]  P. Chambon,et al.  Paracrine signaling through the epithelial estrogen receptor α is required for proliferation and morphogenesis in the mammary gland , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Howlin,et al.  Amphiregulin: Role in Mammary Gland Development and Breast Cancer , 2008, Journal of Mammary Gland Biology and Neoplasia.

[54]  F. Maurer,et al.  The ErbB 2 ErbB 3 heterodimer functions as an oncogenic unit : ErbB 2 requires ErbB 3 to drive breast tumor cell proliferation , 2003, Nature Reviews Cancer.

[55]  J. Settleman,et al.  p190-B RhoGAP regulates mammary ductal morphogenesis. , 2003, Molecular Endocrinology.

[56]  E. Williamson,et al.  BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27Kip1 , 2006, Oncogene.

[57]  C. Daniel,et al.  Reversible inhibition of mammary gland growth by transforming growth factor-beta. , 1987, Science.